Searchable abstracts of presentations at key conferences in endocrinology

ea0063p1027 | Interdisciplinary Endocrinology 2 | ECE2019

Immune-related endocrine toxicities in non-small cell lung cancer: predictors of outcome to checkpoint inhibitors?

Poli Roberta , Dumont Clement , Pietrogiovanna Lisa , Servois Vincent , Beaucaire-Danel Sophie , Daniel Catherine , Girard Nicolas , Romano Emanuela , Hescot Segolene

Background: Immune checkpoint inhibitors (ICIs) are approved for the treatment of non-small cell lung cancer (NSCLC) and are associated with specific immune-related adverse events (iRAEs) including endocrine toxicities. However, data concerning the type, occurrence, and dynamics of iRAEs and their predictive value on treatment outcome are lacking. In this study, we evaluated the relation of iRAEs to anti-PD/L1 (programmed cell death protein/ligand-1) ICIs focusing particularly...

ea0049ep1115 | Female Reproduction | ECE2017

Omentin-1, a potential link between chronic low grade inflammation, metabolic and reproductive features of polycystic ovary syndrome

Shorakae Soulmaz , Abell Sally , de Courten Barbora , Lambert Gavin , Hiam Danielle , Stepto Nigel , Jona Eveline , Moran Lisa , Teede Helena

Background: Polycystic ovary syndrome (PCOS) is associated with features linked to metabolic syndrome including visceral adiposity, dyslipidemia and impaired glucose homeostasis. Adipose tissue produces adipocytokines which contribute to regulation of insulin sensitivity and reproduction. Omentin-1 is an adipokine with anti-inflammatory and insulin sensitizing roles produced by adipocytes. The exact role of mentin-1 in PCOS remains unclear as studies have reported reduced or u...

ea0048o6 | Oral Communications | SFEEU2017

Using Kisspeptin to assess GnRH function in an unusual case of primary amenorrhoea

Narayanaswamy Shakunthala , Vimalesvaran Sunitha , Yang Lisa , Prague Julia K , Miras Alexander D , Franks Stephen , Meeran Karim , Dhillo Waljit S

Case history: An 18-year-old Caucasian female presented with primary amenorrhoea after her younger sister aged 16 years old started menstruating. She had a normal childhood and progressed through puberty normally, with no past medical history or family history. BMI was 22.6 with a normal examination including secondary sexual characteristics (Tanner Stage 5) and no signs of hyperandrogenism.Investigations and Results: Bloods showed an elevated LH:FSH rat...

ea0044p180 | Obesity and Metabolism | SFEBES2016

Metabolic surgery with Roux-en-y Gastric bypass is an effective treatment in patients with Familial Partial Lipodystrophy and Body Mass Index Less than 35 kg/m2

Adams Claire , Savage David , Gaff Lisa , Flanagan Catherine , Jenkins-Liu Charlotte , Semple Robert , Withers Elaine , O'Rahilly Stephen , Stears Anna

Introduction: Familial Partial Lipodystrophy Type 1 (FPLD1) is characterised by loss of gluteal and limb subcutaneous fat and increased abdominal fat. The genetic basis is currently unknown. FPLD1 is frequently associated with metabolic problems including diabetes, insulin resistance, dyslipidaemia and non-alcoholic fatty liver disease. Despite central adiposity and severe metabolic abnormalities, this group of patients often do not qualify for NHS funding for bariatric surger...

ea0059oc6.4 | Neuroendocrinology and Reproduction | SFEBES2018

Kisspeptin receptor activity in human granulosa lutein cells

Owens Lisa , Abbara Ali , Lerner Avi , Christopoulous Georgios , Lavery Stuary , Hardy Kate , Dhillo Waljit , Hanyaloglu Aylin , Franks Stephen

Background: Kisspeptin stimulates gonadotropin secretion indirectly by stimulation of hypothalamic GnRH neurons. Kisspeptin and kisspeptin receptor, a G-protein coupled receptor (GPCR), are also expressed in the human ovary, but their direct actions on ovary, if any, are unclear.Objectives: To examine the direct actions of kisspeptin on granulosa lutein cells (GL cells) and the role of kisspeptin in steroidogenesis.Materials and me...

ea0059p183 | Reproduction | SFEBES2018

Impact of ethnicity on the change in total testosterone, haematocrit and prostate-specific antigen with Testosterone undecanoate treatment

Kempegowda Punith , Quinn Lauren , Rayachaudhari Anupama , Shepherd Lisa , Kauser Samina , Chandan Joht Singh , Thomas Tom , Rahim Asad , Bates Andrew

Background: Current guidelines recommend regular monitoring of total testosterone, haematocrit and prostate-specific antigen (PSA) when androgen-deficient males are commenced on testosterone replacement therapy (TRT). The aim is to restore serum total testosterone to the mid-normal range, whilst maintaining haematocrit and PSA at the recommended levels. Limited studies have assessed the impact of ethnicity on these biochemical parameters.Aim: To measure ...

ea0037gp.15.01 | Diabetes and obesity – basic | ECE2015

Topical application of CD362+ human mesenchymal stem cells (cyndacel-M) seeded in Excellagen scaffold augments wound healing and increases angiogenesis in a diabetic rabbit ulcer model

Patil Swapnil , Chen Xizhe , Watson Luke , Loftus Paul , Flynn Lisa O' , Chandler Lois , Rubanyi Gabor , Elliman Stephen , O'Brien Timothy

Non-healing foot ulcers are a major complication in diabetic patients. Mesenchymal stem cells (MSCs) are known to promote angiogenesis with improved wound healing. Orbsen Therapeutics has identified a novel antibody (CD362+) which can be used to prospectively FACS-isolate CD362+CD45− MSC from human bone marrow with enhanced MSC/MNC purity ratios of up to 1/4. Excellagen matrix was used to seed the cells as biomaterials are well reported t...

ea0037ep1119 | Endocrine tumours | ECE2015

Audit of patients with multiple endocrine neoplasia type 1 (MEN1): screening of pancreatic neuroendocrine tumours (pNETs), parathyroid tumours and pituitary adenomas

Kyithar Ma Pyeh , Cullen Lisa , Lee Chun , Swan Niall , Geoghegan Justin , Skehan Stephen , Crowley Rachel , O'Shea Donal , O'Toole Dermot

Introduction: Patients with MEN1 have increased morbidity and mortality compared to those patients with sporadic NETs. No genotype-phenotype correlation is described and age-related clinical penetrance surpasses 50 and 90% by 20 and 40 years, respectively. The aim of the audit was to compare the screening programme for MEN1 patients with MEN1 clinical guidelines.Methods: Case notes of MEN1 patients attending a tertiary NET-multidisciplinary team (MDT) in...

ea0035p905 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Effect of pasireotide on GH, IGF1, IGFBP2, IGFBP3, HbA1C and glucose in patients with inadequately controlled acromegaly: exploratory results from a multicentre, randomized, 24-week study (PAOLA)

Schmid Herbert , Brue Thierry , Colao Annamaria , Gadelha Monica , Shimon Ilan , Kapur Karen , D'Amato Lisa , Pedroncelli Alberto , Fleseriu Maria

Background: The PAOLA study assessed the efficacy/safety of pasireotide LAR vs continued treatment with octreotide LAR/lanreotide Autogel in patients with inadequately controlled acromegaly. An exploratory objective was to measure changes in various associated biomarkers, including IGF1 and IGFBP2 (released from white fat cells and known to prevent insulin resistance), glucose and HbA1c.Methods: Adult patients (GH >2.5 μg/l and IGF1 >1.3&#21...

ea0060p15 | (1) | UKINETS2018

NETest liquid biopsy is diagnostic of lung neuroendocrine tumors and identifies progressive disease

Malczewska Anna , Kos-Kudla Beata , Filosso Pier-Luigi , Aslanian Harry , Lewczuk Anna , Cwikla Jaroslaw , Rofinella Mateo , Bodei Lisa

Background: There are no effective blood biomarkers for bronchopulmonary carcinoids (BPC). We examined the utility of a neuroendocrine multigene transcript ‘liquid biopsy’ (NETest) in bronchopulmonary carcinoids (BPC) for diagnosis and monitoring of disease status.Aim: To independently validate the utility of the NETest in diagnosis and management of BPC in a prospective multicenter, multinational blinded study.Material a...